Yakira Capital Management’s Kezar Life Sciences KZR Stock Holding History
Bought
Maintained
Sold
Yakira Capital Management's KZR Position: Q2 2026 in Review
Yakira Capital Management sold out of Kezar Life Sciences (KZR) in Q2 2026, closing a stake of 24,000 shares — an estimated $178K sold.
Yakira Capital Management first reported a position in KZR in Q1 2026 and held it in 1 quarter. The position peaked at $178K in Q1 2026. 0 funds tracked by Wall St. Rank hold KZR as of Q2 2026.
- Yakira Capital Management reported no remaining Kezar Life Sciences position as of Q2 2026 after selling out during the quarter.
- Yakira Capital Management sold 24,000 Kezar Life Sciences shares in Q2 2026, an estimated $178K.
- Yakira Capital Management first reported a position in Kezar Life Sciences in Q1 2026 and held it in 1 quarter.
- Yakira Capital Management's Kezar Life Sciences position peaked at $178K in Q1 2026.
- 0 funds tracked by Wall St. Rank held Kezar Life Sciences as of Q2 2026.
Based on Yakira Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.